Microphage Inc.
2400 Trade Centre Avenue
Longmont
Colorado
80503
United States
Tel: 303-339-1422
Fax: 303-339-1411
Website: http://www.microphage.com/
Email: sconlin@micro-phage.com
24 articles about Microphage Inc.
-
Microphage Inc. Seeks Bankruptcy Protection
1/4/2013
-
Microphage Inc. Leads the Way to Early Appropriate Treatment for Dangerous MRSA and MSSA Bloodstream Infections
7/11/2012
-
Microphage Inc. KeyPath(TM) Test Receives Expanded Clearance
4/17/2012
-
Microphage Inc. KeyPath(TM) Test Receives Expanded Clearance
4/17/2012
-
Microphage Inc. Partners with Cardinal Health, Inc. on Funding, Marketing First One-Day Susceptibility Test
10/11/2011
-
Microphage Inc. KeyPath(TM) AST Clinical Trial Data Presented at the Upcoming American Society of Microbiology
5/20/2011
-
Microphage Inc. Announces the Formation of Its Medical Advisory Board
5/13/2011
-
Microphage Inc. Names Don Mooney to Serve as New CEO
2/7/2011
-
Microphage Inc. Names Mel Schatz to Board of Directors
10/1/2010
-
Microphage Inc. Wins R&D Magazine 100 Award' For World's First Test Designed To Rapidly Identify Bacterial Infections And Antibiotic Susceptibility
7/27/2010
-
Microphage Inc. Launches World’s First Diagnostics for Antibiotic Testing and Bacterial Identification in Just Five Hours or Less Compared to up to Three Days for Other Tests
5/24/2010
-
Microphage Inc. Appoints Alene A. Campbell as CEO
3/18/2010
-
Microphage Inc. Seeks FDA Clearance to Market World's First Test Designed to Rapidly Identify Bacterial Infections and Antibiotic Susceptibility
3/5/2010
-
Microphage Inc. Concludes Pivotal Clinical Study of World's First Test Designed to Rapidly Identify Bacterial Infections and Antibiotic Susceptibility without Costly Equipment
1/12/2010
-
Former Premier, Inc. CEO Richard Norling to Join Microphage Inc. Board of Directors
10/13/2009
-
Microphage Inc. Opens Pivotal FDA Study on Bacterial Identification Platform
8/20/2009
-
Microphage Inc. Results on Rapid S. aureus/MRSA Blood Culture Test Published
5/22/2009
-
Microphage Inc. Demonstrates Rapid Diagnostic Platform Feasibility in Skin and Soft Tissue Infections
5/18/2009
-
Microphage Inc. Successfully Completes Beta Trial for Rapid MRSA Test
1/14/2009
-
Microphage Inc. Selects Lynn Taussig, MD for Board of Directors
12/2/2008